Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q1 2023 · 10-Q
Revenue$666.20M$666.20M+11.7% vs Q1 2022 Net Income-$24.90M-$24.90MN/M vs Q1 2022 EPS Diluted-$0.20-$0.20N/M vs Q1 2022 Operating Income$46,400,000−53.8% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
Free Cash Flowderived$50,200,000−18.5% Margins · derivedOperating margin7.0%−9.9 pt vs Q1 2022
Net margin-3.7%−5.8 pt vs Q1 2022
ended Mar 31, 2023 · filed May 2, 2023 · 32 d after period end